Skip to main content
. 2023 Jan 6;10:1081233. doi: 10.3389/fbioe.2022.1081233

FIGURE 5.

FIGURE 5

Representative products of four companies. (A) Cytograft Tissue Engineering Inc.—The Lifeline™ graft: a completely biological, living, and autologous human blood vessel. The Lifeline™ graft displays remarkably high burst pressure, even though it contains no scaffolding materials, and also shows good suture retention abilities as well as remarkable flexibility (L’Heureux and McAllister, 2008). (B) Humacyte, Inc., —Human acellular vessels (HAVs): gross photos of engineered human acellular vessels, 6 mm in diameter (Niklason and Lawson, 2020). (C) Vascudyne, Inc. —Arteriovenous graft (AVG): side view and end-on view image of a 6-mm-diameter decellularized tissue-engineered vascular graft (Syedain et al., 2017). (D) LeMaitre Vascular, Inc., —Artegraft®: a bovine carotid artery (BCA) graft before tunneling (Pineda et al., 2017).